$NVAX NOVAVAX INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NOVAVAX INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NOVAVAX INC. Insider overview, share value development, latest insider transactions and email notifications about new events in NOVAVAX INC for free.

CIK Number: 0001000694
IRS Number: 222816046
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: NVAX
Company Address: 21 FIRSTFIELD ROAD GAITHERSBURG 20878

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Market Capitalization: $355.26M
Prev close: $1.31
Average Daily Volume: 7,103,670
Days Low: $1.28
Year Low: $1.16
Year High: $8.49

NOVAVAX INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
EVANS GRAY CDirector18,09923,710shares bought: 35,000 / shares sold: -103,998 STRONG SELLMar 17 20212 months ago
Glenn Gregory MPresident, R&D3,4304,493shares bought: 259,199 / shares sold: -192,065 BUYApr 19 202117 days ago
Herrmann John A IIIEVP, Chief Legal Officer691905shares bought: 149,530 / shares sold: -144,924 BUYMar 30 20211 month ago
MCMANUS MICHAEL A JRDirector8,95111,726shares bought: 68,000 / shares sold: -15,929 STRONG BUYMar 23 20211 month ago
Trizzino JohnEVP, Chief Commercial Officer704922shares bought: 236,340 / shares sold: -143,961 BUYApr 07 202129 days ago
YOUNG JAMES FDirector20,00026,200shares bought: 80,000 / shares sold: -296,000 STRONG SELLMar 25 20211 month ago

View all NOVAVAX INC insiders.

NOVAVAX INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.954,81928,67351,643
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.953,12418,58865,628
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM46.001,10150,64615,221
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.954,81928,67351,643
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.6086823,9575,737
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.953,12418,58865,628
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.0061916,7131,242
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM46.001,10150,64615,221
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS224.50494110,9052,8113.3 K to 2.8 K (-14.95 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.6086823,9575,737
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS221.6735678,9153,3053.7 K to 3.3 K (-9.72 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.0061916,7131,242
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS220.5743796,3903,6614.1 K to 3.7 K (-10.66 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS224.50494110,9052,8113.3 K to 2.8 K (-14.95 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS219.178117,7534,0984.2 K to 4.1 K (-1.94 %)

View all NOVAVAX INC insider transactions.